The panel discussion, “Innovations in Breast Cancer Treatment,” examined the challenge of maintaining or increasing access to care as breast cancer treatment becomes more stratified through biomarker ...
Blau Farmacêutica, a Brazilian pharmaceutical company listed on Brazilian Stock Market (B3) and a regional leader in hospital pharmaceuticals with a strong presence across Latin America, announces an ...
By CH Unnikrsihnan Drug maker and researcher Glenmark Pharmaceuticals Ltd's new biological drug candidate Bi-Specific ...
Clinical Trials Arena on MSN
ImmunityBio’s glioblastoma regimen boosts survival in mid-stage study
As of 22 January, 19 of the 23 patients who have received treatment are still alive, with the longest evaluable survival ...
MedPage Today on MSN
Preservatives and Cancer; Pre-Op Therapy Gains Momentum; Speedier Myeloma Approvals
News, features, and commentary about cancer-related issues ...
The results of the phase 3 MajesTEC-9 trial showcase teclistamab's efficacy for patients with relapsed/refractory multiple ...
News-Medical.Net on MSN
Dual-responsive nanodelivery system enhances immunotherapy efficacy in metastatic bladder cancer
Metastatic urothelial carcinoma has a poor prognosis: ~50% of muscle-invasive bladder cancer progresses to metastasis, and ...
Kamini Walia, senior scientist at ICMR (Indian Council of Medical Research), explains how the overuse of antibiotics is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results